Development asset linked to 60 DEGREES PHARMACEUTICALS in public FDA and regional records.
pharma · Dengue Fever · Chronic Babesiosis · SXTP
60 DEGREES PHARMACEUTICALS
60 DEGREES PHARMACEUTICALS, INC.
60 DEGREES PHARMACEUTICALS drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Washington, USA HQ
2010 Founded
6 Employees
Public company Type
SXTP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Washington, USA
- Founded
- 2010
- Employees
- 6
- Programs
- 5
- Drugs
- 2
- Patents
- 0
60 DEGREES PHARMACEUTICALS pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
60 DEGREES PHARMACEUTICALS drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown